Rac1 GTPase Regulates the SCFβTrCP-Mediated Degradation of Claspin and the Cellular Response of Pancreatic Cancer

Neha Chaudhary1,2, Tabbatha N Somers1, Surinder K Batra2

  • 1Department Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198, USA.

Cancers
|June 26, 2026
PubMed
Abstract

Insights

Rac1 inhibition degrades Claspin, impairing DNA damage response in pancreatic cancer cells. This sensitizes cancer cells, but not normal cells, to radiation therapy by disrupting ATR/Chk1 signaling.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Signaling

Background:

  • Pancreatic ductal adenocarcinomas (PDACs) are lethal and resistant to therapies.
  • The KRAS oncogene drives PDAC, with tumors reliant on its effectors like Rac1.
  • Rac1 regulates DNA damage response and actin remodeling.

Purpose of the Study:

  • Investigate Rac1's role in DNA damage response pathways in PDAC.
  • Determine the mechanism by which Rac1 inhibition affects ATR/Chk1 signaling.
  • Assess the therapeutic potential of targeting Rac1 in PDAC.

Main Methods:

  • Western blot analysis to study ATR/Chk1 cascade components.
  • Rac1 inhibition using chemical inhibitors and siRNA.
  • Assessment of Claspin protein levels, mRNA, and half-life.
  • Analysis of proteasomal degradation and involvement of βTrCP1/2.

Main Results:

  • Rac1 inhibition decreases Claspin protein levels by promoting its degradation.
  • Claspin degradation is proteasome- and βTrCP1/2-dependent in PDAC cells.
  • PDAC cells are more vulnerable to Claspin depletion and gamma-ray-induced apoptosis than normal cells.
  • Rac1 inhibition impairs Chk1 activation in response to DNA damage.

Conclusions:

  • Rac1 is crucial for stabilizing Claspin, a key component of the fork protection complex.
  • Rac1 inhibition leads to βTrCP-dependent degradation of Claspin, hindering Chk1 activation.
  • Targeting Rac1 sensitizes PDAC cells to DNA-damaging agents by disrupting ATR/Chk1 signaling.

Related Concept Videos

Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...